Nutrien (NTR) Company Report

Analyst Coverage

Research analysts who have asked questions during Nutrien earnings calls.

Andrew Wong

RBC Capital Markets

6 questions for NTR

Also covers: CCJ, CF, LGO +3 more

Ben Isaacson

Scotiabank

6 questions for NTR

Also covers: ALB, LAAC, LAR +4 more

Edlain Rodriguez

Mizuho Securities

6 questions for NTR

Also covers: ALB, BALL, CCK +6 more

Jeffrey Zekauskas

JPMorgan Chase & Co.

6 questions for NTR

Also covers: ALB, APD, ASH +30 more

Joel Jackson

BMO Capital Markets

6 questions for NTR

Also covers: AGCO, ALB, ALTM +11 more

Lucas Beaumont

UBS Group AG

6 questions for NTR

Also covers: AXTA, CF, IPI +4 more

Vincent Andrews

Morgan Stanley

6 questions for NTR

Also covers: ALB, APD, AVNT +20 more

Steven Hansen

Raymond James

5 questions for NTR

Also covers: ALTG, CNI, CP +2 more

Kristen Owen

Oppenheimer & Co. Inc.

4 questions for NTR

Also covers: , AGCO, AVNT +15 more

Richard Garchitorena

Wells Fargo

4 questions for NTR

Also covers: CF, CTVA, DOW +2 more

Benjamin Theurer

Barclays Corporate & Investment Bank

3 questions for NTR

Also covers: ADM, BG, BYND +15 more

Christopher Parkinson

Wolfe Research

3 questions for NTR

Also covers: ALB, APD, ASH +17 more

Hamir Patel

CIBC Capital Markets

3 questions for NTR

Also covers: MEOH, MERC, WFG +1 more

Steve Byrne

Bank of America

3 questions for NTR

Also covers: ADM, APD, AXTA +19 more

Aron Ceccarelli

Berenberg

2 questions for NTR

Also covers: CF, MOS, PPG +1 more

Ben Theurer

Barclays

2 questions for NTR

Also covers: ADM, CX, HRL +5 more

Chris Parkinson

Wolfe Research, LLC

2 questions for NTR

Also covers: AXTA, CCK, CTVA +6 more

David Symonds

BNP Paribas

2 questions for NTR

Also covers: MOS

Jordan Lee

Goldman Sachs

2 questions for NTR

Also covers: CF, SFD

Michael Doumet

National Bank Financial

2 questions for NTR

Also covers: GFL, WCN

Salvator Tiano

Bank of America

2 questions for NTR

Also covers: ADM, BG, CE +7 more

Adam Samuelson

The Goldman Sachs Group, Inc.

1 question for NTR

Also covers: BERY, HRL, LW +2 more

Andrew Rosivach

Wolfe Research

1 question for NTR

Ariana Milin

CIBC Capital Markets

1 question for NTR

Jacob Bout

CIBC

1 question for NTR

Also covers: STN

Matthew Deyoe

Bank of America

1 question for NTR

Also covers: APD, AXTA, CF +12 more

Michael Tupholme

TD Cowen

1 question for NTR

Also covers: STN

Patrick Fischer

Goldman Sachs

1 question for NTR

Also covers: APD, AXTA, CC +8 more

Rahi Parikh

Barclays

1 question for NTR

Also covers: BG, HRL, ICL +1 more

Latest news

Recent press releases and 8-K filings for NTR.

Nutrien Completes Sale of Profertil Equity Position

NTR

M&A

Share Buyback

Debt Issuance

Nutrien Ltd. completed the sale of its 50 percent equity position in Argentina-based nitrogen producer Profertil S.A. on December 10, 2025.
The transaction generated approximately US$600 million in pre-tax proceeds.
The company intends to allocate these proceeds towards capital allocation priorities, including targeted growth investments, share repurchases, and debt reduction.
This sale contributes to Nutrien's total of approximately US$900 million in gross proceeds from asset divestitures since the fourth quarter of 2024.

Dec 10, 2025, 9:30 PM

6-K

Nutrien Completes Sale of Profertil S.A. Equity Position

NTR

M&A

Share Buyback

New Projects/Investments

Nutrien has completed the sale of its 50 percent equity position in Argentina-based nitrogen producer Profertil S.A. to Adecoagro S.A. and Asociacion de Cooperativas Argentinas Coop Ltda.
The sale generated approximately US$600 million in pre-tax proceeds, contributing to a total of approximately US$900 million in gross proceeds from asset divestitures since the fourth quarter of 2024.
The company intends to allocate these proceeds towards capital allocation priorities, including targeted growth investments, share repurchases, and debt reduction.

Dec 10, 2025, 9:15 PM

Press Release

Nutrien Reports Strong Q3 2025 Results, Raises Potash Guidance, and Initiates Phosphate Business Review

NTR

Earnings

Guidance Update

M&A

Nutrien reported Q3 2025 adjusted EBITDA of $1.4 billion, a 42% increase compared to the prior year, and raised its full-year potash sales volume guidance to 14-14.5 million tons.
The company is on track to achieve its $200 million cost reduction target one year ahead of schedule, contributing to a 5% reduction in SE&A expenses through the first nine months of 2025.
A strategic review of the phosphate business has been initiated, exploring alternatives such as reconfiguring operations, strategic partnerships, or a potential sale, with conclusions expected in 2026. Divestitures of other non-core assets are expected to generate approximately $900 million in gross proceeds.
Through the first nine months of 2025, Nutrien allocated $1.2 billion to dividends and share repurchases, representing a 42% increase from the prior year.
Global potash shipments are projected to be 73-75 million tons in 2025 and 74-77 million tons in 2026, indicating continued demand growth.

Nov 6, 2025, 3:00 PM

Transcript

Nutrien Reports Strong Q3 2025 Results, Updates Guidance, and Advances Strategic Portfolio Review

NTR

Earnings

Guidance Update

M&A

Nutrien reported Q3 2025 adjusted EBITDA of $1.4 billion, a 42% increase compared to the prior year, driven by strong contributions from potash, nitrogen, and retail segments.
The company raised its full-year potash sales volume guidance to 14-14.5 million tons and narrowed its full-year retail adjusted EBITDA guidance to $1.68 billion-$1.82 billion.
Nutrien is on track to achieve its $200 million cost reduction target one year ahead of schedule and has reduced capital expenditures by 10% year-to-date.
Strategic portfolio actions include expected $900 million in gross proceeds from non-core asset divestitures and the initiation of a strategic review for its phosphate business, which contributes about 6% of EBITDA.
The company allocated $1.2 billion to dividends and share repurchases in the first nine months of 2025, representing a 42% increase from the prior year.

Nov 6, 2025, 3:00 PM

Transcript

Nutrien Reports Strong Q3 2025 Results, Updates Guidance, and Advances Strategic Portfolio Review

NTR

Earnings

Guidance Update

M&A

Nutrien reported Q3 2025 adjusted EBITDA of $1.4 billion, a 42% increase compared to the prior year, with retail adjusted EBITDA up 52%.
The company raised its full-year potash sales volume guidance to 14-14.5 million tons and narrowed its full-year retail adjusted EBITDA guidance to $1.68 billion-$1.82 billion. Global potash shipments are projected to reach 73-75 million tons in 2025 and 74-77 million tons in 2026.
Nutrien is on track to achieve its $200 million cost reduction target a year early and expects approximately $900 million in gross proceeds from non-core asset divestitures.
A strategic review of the phosphate business has been initiated, and the Trinidad nitrogen operations, which contributed approximately 1% of 2025 consolidated free cash flow, were shut down.
The company allocated $1.2 billion to dividends and share repurchases in the first nine months, a 42% increase from the prior year.

Nov 6, 2025, 3:00 PM

Transcript

Nutrien Declares Quarterly Dividend and Reports Strong Q3 2025 Results

NTR

Dividends

Earnings

New Projects/Investments

Nutrien Ltd. announced a quarterly dividend of US$0.545 per share, payable on January 16, 2026, to shareholders of record as of December 31, 2025.
The company reported strong third-quarter 2025 results, including $0.5 billion in net earnings and $6.0 billion in revenue.
Nutrien is strategically reducing capital expenditures while increasing shareholder returns, and is reviewing strategic alternatives for its Phosphate business and plans to sell its stake in Profertil S.A. to fund growth investments, share repurchases, and debt reduction.
Analysts maintain a neutral rating on Nutrien stock, citing strong cash flow and operational performance, with a positive outlook fueled by anticipated strong crop input demand and increased global potash shipments by 2026.

Nov 6, 2025, 11:36 AM

Morningstar

Nutrien Reports Q3 2025 Results and Initiates Phosphate Business Review

NTR

Earnings

M&A

Share Buyback

Nutrien reported net earnings of $0.5 billion and adjusted EBITDA of $1.4 billion for the third quarter of 2025, with diluted net earnings per share of $0.96.
For the first nine months of 2025, the company generated net earnings of $1.7 billion and adjusted EBITDA of $4.8 billion.
Nutrien is initiating a review of strategic alternatives for its Phosphate business to enhance long-term value.
The company returned $1.2 billion to shareholders in the first nine months of 2025 through dividends and share repurchases, including 8.3 million shares repurchased for $465 million as of November 4, 2025.

Nov 5, 2025, 10:54 PM

6-K

Nutrien Commences Shutdown of Trinidad Nitrogen Operations

NTR

Guidance Update

New Projects/Investments

Nutrien Ltd. has initiated a controlled shut down of its Trinidad Nitrogen operations, effective October 23, 2025.
The shutdown is a response to port access restrictions imposed by Trinidad and Tobago’s National Energy Corporation (NEC) and a lack of reliable and economic natural gas supply, which have negatively impacted free cash flow from these operations.
The Trinidad operations contribute approximately 85 thousand tonnes of ammonia and 55 thousand tonnes of urea in monthly sales volumes.
Despite the shutdown, Nutrien anticipates staying within its 2025 annual nitrogen sales volume guidance range of 10.7 to 11.2 million tonnes, supported by strong performance in its North American Nitrogen operations.

Oct 21, 2025, 1:50 PM

6-K

Nutrien Halts Trinidad Nitrogen Operations

NTR

Guidance Update

Nutrien has initiated a controlled shutdown of its nitrogen production at the Point Lisas facility in Trinidad, effective October 23, due to port access restrictions and unreliable, costly natural gas supplies.
This shutdown has impacted the free cash flow contribution from the Trinidad operations.
Despite the temporary halt, Nutrien remains confident in meeting its 2025 nitrogen sales volume guidance of 10.7 to 11.2 million metric tons, supported by its strong North American operations.

Oct 21, 2025, 1:20 PM

Morningstar

Nutrien Commences Controlled Shutdown of Trinidad Nitrogen Operations

NTR

Guidance Update

Nutrien Ltd. is commencing a controlled shutdown of its Trinidad Nitrogen operations at the Point Lisas’ facility, effective October 23, 2025.
The shutdown is a response to port access restrictions imposed by Trinidad and Tobago’s National Energy Corporation (NEC) and a lack of reliable and economic natural gas supply.
These issues have reduced the free cash flow contribution from the Trinidad Nitrogen operations over an extended period.
Despite the shutdown, Nutrien expects to remain within its 2025 annual nitrogen sales volume guidance range of 10.7 to 11.2 million tonnes due to strong performance from its North American Nitrogen operations.